ArticleCell biochemistry and biophysics2024

Unveiling therapeutic frontiers: DON/DRP-104 as innovative Plasma kallikrein inhibitors against carcinoma-associated hereditary angioedema shocks - a comprehensive molecular dynamics exploration.

Ernest Oduro-Kwateng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.